loader
Please Wait
Applying Filters...

AbbVie Header AbbVie Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Ebopiprant, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Ebopiprant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

    Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    2D Structure
    1. Also known as: Ebopiprant [inn], Obe022, Obe-022, Z1avz44tej, 2005486-31-5, (3s)-3-((2s)-3-((1,1'-biphenyl)-4-sulfonyl)-1,3-thiazolidine-2-carboxamido)-3-(4-fluorophenyl)propyl l-valinate
    Molecular Formula
    C30H34FN3O5S2
    Molecular Weight
    599.7  g/mol
    InChI Key
    UUIBKACUTXYSAK-YCVJPRETSA-N
    FDA UNII
    Z1AVZ44TEJ
    Ebopiprant is under investigation in clinical trial NCT03369262 (Poc Study of OBE022 in Threatened Preterm Labour).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(3S)-3-(4-fluorophenyl)-3-[[(2S)-3-(4-phenylphenyl)sulfonyl-1,3-thiazolidine-2-carbonyl]amino]propyl] (2S)-2-amino-3-methylbutanoate
    2.1.2 InChI
    InChI=1S/C30H34FN3O5S2/c1-20(2)27(32)30(36)39-18-16-26(23-8-12-24(31)13-9-23)33-28(35)29-34(17-19-40-29)41(37,38)25-14-10-22(11-15-25)21-6-4-3-5-7-21/h3-15,20,26-27,29H,16-19,32H2,1-2H3,(H,33,35)/t26-,27-,29-/m0/s1
    2.1.3 InChI Key
    UUIBKACUTXYSAK-YCVJPRETSA-N
    2.1.4 Canonical SMILES
    CC(C)C(C(=O)OCCC(C1=CC=C(C=C1)F)NC(=O)C2N(CCS2)S(=O)(=O)C3=CC=C(C=C3)C4=CC=CC=C4)N
    2.1.5 Isomeric SMILES
    CC(C)[C@@H](C(=O)OCC[C@@H](C1=CC=C(C=C1)F)NC(=O)[C@H]2N(CCS2)S(=O)(=O)C3=CC=C(C=C3)C4=CC=CC=C4)N
    2.2 Other Identifiers
    2.2.1 UNII
    Z1AVZ44TEJ
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (s)-2-amino-3-methyl-butyric Acid (s)-3-(((s)-3-(biphenyl-4-sulfonyl)-thiazolidine-2-carbonyl)-amino)-3-(4-fluoro-phenyl)-propyl Ester

    2. Obe022

    2.3.2 Depositor-Supplied Synonyms

    1. Ebopiprant [inn]

    2. Obe022

    3. Obe-022

    4. Z1avz44tej

    5. 2005486-31-5

    6. (3s)-3-((2s)-3-((1,1'-biphenyl)-4-sulfonyl)-1,3-thiazolidine-2-carboxamido)-3-(4-fluorophenyl)propyl L-valinate

    7. [(3s)-3-(4-fluorophenyl)-3-[[(2s)-3-(4-phenylphenyl)sulfonyl-1,3-thiazolidine-2-carbonyl]amino]propyl] (2s)-2-amino-3-methylbutanoate

    8. L-valine, (3s)-3-((((2s)-3-((1,1'-biphenyl)-4-ylsulfonyl)-2-thiazolidinyl)carbonyl)amino)-3-(4-fluorophenyl)propyl Ester

    9. Unii-z1avz44tej

    10. Ebopiprant [who-dd]

    11. Chembl3975522

    12. Schembl18055682

    13. Bdbm244799

    14. Us9447055, I

    15. Hy-112284

    16. Cs-0044706

    2.4 Create Date
    2016-12-08
    3 Chemical and Physical Properties
    Molecular Weight 599.7 g/mol
    Molecular Formula C30H34FN3O5S2
    XLogP34.9
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count12
    Exact Mass599.19239170 g/mol
    Monoisotopic Mass599.19239170 g/mol
    Topological Polar Surface Area153 Ų
    Heavy Atom Count41
    Formal Charge0
    Complexity956
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY